好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Evolving Burden of Mortality due to Paralytic Syndromes in the United States (1999-2023): Insights from a 24-year Mortality Analysis
General Neurology
P7 - Poster Session 7 (8:00 AM-9:00 AM)
7-009

This study aims to assess national trends in paralytic syndrome-related mortality in the United States from 1999 to 2023, stratified by age, sex, race/ethnicity, region, and urbanization status.

Paralytic syndromes include a broad range of neurological disorders that cause muscle weakness or paralysis due to damage or dysfunction of the upper or lower motor neurons. Despite advances in neurocritical care and rehabilitation, population-level data on mortality trends associated with paralytic syndromes remain limited.

We analyzed the CDC WONDER dataset to examine trends in paralytic syndromes-related mortality among adults aged ≥25 years in the US from 1999 to 2023, using ICD-10 codes: G81-G83. Age-Adjusted Mortality Rates (AAMR) per 100,000 were calculated and categorized by demographics and region. Joinpoint regression was used to estimate Annual Percent Change (APC) and Average Annual Percent Change (AAPC).

From 1999 to 2023, paralytic syndromes caused 202,915 deaths among adults aged ≥25 years. The overall AAMR remained stable from 4.88 to 4.59 (AAPC: 0.04; 95% CI: -0.97 to 1.08). Men consistently had higher AAMRs than women throughout the study period. AAMRs increased from 1999 to 2023, among NH Blacks (7.07 to 7.42), and Hispanics (3.91 to 4.25). In contrast, AAMRs declined among NH Whites (4.72 to 4.4), NH Asians (4.42 to 2.98), and NH American Indians (6.99 to 4.78). Regionally, increases were noted in the South and West, while declines were noted in Northeast and Midwest. Non-metropolitan areas had higher mortality than metropolitan areas.

Paralytic syndrome-related mortality in the United States has remained largely stable over the past two decades, yet significant demographic and geographic disparities persist. Higher mortality among men, minority populations, and residents of rural regions underscores the need for targeted prevention strategies, improved access to neurological care, and further investigation into underlying social and clinical determinants of high mortality.

Authors/Disclosures
Eshal Saghir, MBBS
PRESENTER
Miss Saghir has nothing to disclose.
Maryam Saghir, MBBS Miss Saghir has nothing to disclose.
Muhammad Affan, MBBS Dr. Affan has nothing to disclose.
Mahtab zafar, MBBS Dr. zafar has nothing to disclose.
Nara Michaelson, MD (Beth Israel Deaconess Medical Center) The institution of Dr. Michaelson has received research support from Biogen. The institution of Dr. Michaelson has received research support from the National Multiple Sclerosis Society (NMSS). Dr. Michaelson has received research support from Sanofi.